Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy
Gespeichert in:
| Veröffentlicht in: | British journal of haematology 2021-01, Vol.192 (2), p.e38-e42 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e42 |
|---|---|
| container_issue | 2 |
| container_start_page | e38 |
| container_title | British journal of haematology |
| container_volume | 192 |
| creator | Jain, Preetesh Nastoupil, Loretta Westin, Jason Lee, Hun Ju Navsaria, Lucy Steiner, Raphael E. Ahmed, Sairah Moghrabi, Omar Oriabure, Onyeka Chen, Wendy Badillo, Maria Flowers, Christopher R. Wang, Michael L. |
| description | |
| doi_str_mv | 10.1111/bjh.17197 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2458034789</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2458034789</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3887-2406b20040b2234a8e4c4d5ce2993dc4382b44320deecf051d3dbf14a1b55aa63</originalsourceid><addsrcrecordid>eNp1kV1LwzAUhoMobn5c-Ack4I1edMtX1-5ShzplsBu9Lkl6unW0TU1SZv-9mZteCIZAAufJwzl5EbqiZETDGqvNekQTOk2O0JDySRwxKugxGhJCkogSkQ7QmXMbQignMT1FA85pzEJhiPyy89rU4LBsclzLRq6ghsZjU-BW-jJcHd6Wfr2r-QqwhqrCVV-3a1NLLAsPFrfWrCw4V5oGh60sfHZaKh9cDWDZeVNBFx5ivwYr2_4CnRSycnB5OM_R-9Pj22weLZbPL7P7RaR5miYRE2SiGCGCKMa4kCkILfJYA5tOea4FT5kSgjOSA-giTJbzXBVUSKriWMoJP0e3e29o8KMD57O6dLsBZAOmcxkTcUq4SNJpQG_-oBvT2SZ0F6gkFYkQlAXqbk9pa5yzUGStLWtp-4ySbBdFFqLIvqMI7PXB2Kka8l_y5-8DMN4D27KC_n9T9vA63yu_AOYtk8Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2478474412</pqid></control><display><type>article</type><title>Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy</title><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>Wiley Online Library All Journals</source><creator>Jain, Preetesh ; Nastoupil, Loretta ; Westin, Jason ; Lee, Hun Ju ; Navsaria, Lucy ; Steiner, Raphael E. ; Ahmed, Sairah ; Moghrabi, Omar ; Oriabure, Onyeka ; Chen, Wendy ; Badillo, Maria ; Flowers, Christopher R. ; Wang, Michael L.</creator><creatorcontrib>Jain, Preetesh ; Nastoupil, Loretta ; Westin, Jason ; Lee, Hun Ju ; Navsaria, Lucy ; Steiner, Raphael E. ; Ahmed, Sairah ; Moghrabi, Omar ; Oriabure, Onyeka ; Chen, Wendy ; Badillo, Maria ; Flowers, Christopher R. ; Wang, Michael L.</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.17197</identifier><identifier>PMID: 33152104</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; brexucabtagene autoleucel ; BTK inhibitor ; chimeric antigen receptor therapy ; Disease Management ; Female ; Hematology ; Humans ; ibrutinib ; Immunotherapy, Adoptive - methods ; Lymphoma, Mantle-Cell - therapy ; Male ; Mantle cell lymphoma ; Mantle cell lymphoma (MCL) ; Middle Aged ; non‐Hodgkin lymphoma ; Receptors, Chimeric Antigen - therapeutic use ; Survival Analysis ; Treatment Outcome ; venetoclax</subject><ispartof>British journal of haematology, 2021-01, Vol.192 (2), p.e38-e42</ispartof><rights>2020 British Society for Haematology and John Wiley & Sons Ltd</rights><rights>Copyright © 2021 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3887-2406b20040b2234a8e4c4d5ce2993dc4382b44320deecf051d3dbf14a1b55aa63</citedby><cites>FETCH-LOGICAL-c3887-2406b20040b2234a8e4c4d5ce2993dc4382b44320deecf051d3dbf14a1b55aa63</cites><orcidid>0000-0003-2735-168X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.17197$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.17197$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27903,27904,45553,45554,46388,46812</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33152104$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jain, Preetesh</creatorcontrib><creatorcontrib>Nastoupil, Loretta</creatorcontrib><creatorcontrib>Westin, Jason</creatorcontrib><creatorcontrib>Lee, Hun Ju</creatorcontrib><creatorcontrib>Navsaria, Lucy</creatorcontrib><creatorcontrib>Steiner, Raphael E.</creatorcontrib><creatorcontrib>Ahmed, Sairah</creatorcontrib><creatorcontrib>Moghrabi, Omar</creatorcontrib><creatorcontrib>Oriabure, Onyeka</creatorcontrib><creatorcontrib>Chen, Wendy</creatorcontrib><creatorcontrib>Badillo, Maria</creatorcontrib><creatorcontrib>Flowers, Christopher R.</creatorcontrib><creatorcontrib>Wang, Michael L.</creatorcontrib><title>Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>brexucabtagene autoleucel</subject><subject>BTK inhibitor</subject><subject>chimeric antigen receptor therapy</subject><subject>Disease Management</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>ibrutinib</subject><subject>Immunotherapy, Adoptive - methods</subject><subject>Lymphoma, Mantle-Cell - therapy</subject><subject>Male</subject><subject>Mantle cell lymphoma</subject><subject>Mantle cell lymphoma (MCL)</subject><subject>Middle Aged</subject><subject>non‐Hodgkin lymphoma</subject><subject>Receptors, Chimeric Antigen - therapeutic use</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><subject>venetoclax</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kV1LwzAUhoMobn5c-Ack4I1edMtX1-5ShzplsBu9Lkl6unW0TU1SZv-9mZteCIZAAufJwzl5EbqiZETDGqvNekQTOk2O0JDySRwxKugxGhJCkogSkQ7QmXMbQignMT1FA85pzEJhiPyy89rU4LBsclzLRq6ghsZjU-BW-jJcHd6Wfr2r-QqwhqrCVV-3a1NLLAsPFrfWrCw4V5oGh60sfHZaKh9cDWDZeVNBFx5ivwYr2_4CnRSycnB5OM_R-9Pj22weLZbPL7P7RaR5miYRE2SiGCGCKMa4kCkILfJYA5tOea4FT5kSgjOSA-giTJbzXBVUSKriWMoJP0e3e29o8KMD57O6dLsBZAOmcxkTcUq4SNJpQG_-oBvT2SZ0F6gkFYkQlAXqbk9pa5yzUGStLWtp-4ySbBdFFqLIvqMI7PXB2Kka8l_y5-8DMN4D27KC_n9T9vA63yu_AOYtk8Y</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Jain, Preetesh</creator><creator>Nastoupil, Loretta</creator><creator>Westin, Jason</creator><creator>Lee, Hun Ju</creator><creator>Navsaria, Lucy</creator><creator>Steiner, Raphael E.</creator><creator>Ahmed, Sairah</creator><creator>Moghrabi, Omar</creator><creator>Oriabure, Onyeka</creator><creator>Chen, Wendy</creator><creator>Badillo, Maria</creator><creator>Flowers, Christopher R.</creator><creator>Wang, Michael L.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2735-168X</orcidid></search><sort><creationdate>202101</creationdate><title>Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy</title><author>Jain, Preetesh ; Nastoupil, Loretta ; Westin, Jason ; Lee, Hun Ju ; Navsaria, Lucy ; Steiner, Raphael E. ; Ahmed, Sairah ; Moghrabi, Omar ; Oriabure, Onyeka ; Chen, Wendy ; Badillo, Maria ; Flowers, Christopher R. ; Wang, Michael L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3887-2406b20040b2234a8e4c4d5ce2993dc4382b44320deecf051d3dbf14a1b55aa63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>brexucabtagene autoleucel</topic><topic>BTK inhibitor</topic><topic>chimeric antigen receptor therapy</topic><topic>Disease Management</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>ibrutinib</topic><topic>Immunotherapy, Adoptive - methods</topic><topic>Lymphoma, Mantle-Cell - therapy</topic><topic>Male</topic><topic>Mantle cell lymphoma</topic><topic>Mantle cell lymphoma (MCL)</topic><topic>Middle Aged</topic><topic>non‐Hodgkin lymphoma</topic><topic>Receptors, Chimeric Antigen - therapeutic use</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><topic>venetoclax</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jain, Preetesh</creatorcontrib><creatorcontrib>Nastoupil, Loretta</creatorcontrib><creatorcontrib>Westin, Jason</creatorcontrib><creatorcontrib>Lee, Hun Ju</creatorcontrib><creatorcontrib>Navsaria, Lucy</creatorcontrib><creatorcontrib>Steiner, Raphael E.</creatorcontrib><creatorcontrib>Ahmed, Sairah</creatorcontrib><creatorcontrib>Moghrabi, Omar</creatorcontrib><creatorcontrib>Oriabure, Onyeka</creatorcontrib><creatorcontrib>Chen, Wendy</creatorcontrib><creatorcontrib>Badillo, Maria</creatorcontrib><creatorcontrib>Flowers, Christopher R.</creatorcontrib><creatorcontrib>Wang, Michael L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jain, Preetesh</au><au>Nastoupil, Loretta</au><au>Westin, Jason</au><au>Lee, Hun Ju</au><au>Navsaria, Lucy</au><au>Steiner, Raphael E.</au><au>Ahmed, Sairah</au><au>Moghrabi, Omar</au><au>Oriabure, Onyeka</au><au>Chen, Wendy</au><au>Badillo, Maria</au><au>Flowers, Christopher R.</au><au>Wang, Michael L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2021-01</date><risdate>2021</risdate><volume>192</volume><issue>2</issue><spage>e38</spage><epage>e42</epage><pages>e38-e42</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>33152104</pmid><doi>10.1111/bjh.17197</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-2735-168X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1048 |
| ispartof | British journal of haematology, 2021-01, Vol.192 (2), p.e38-e42 |
| issn | 0007-1048 1365-2141 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2458034789 |
| source | MEDLINE; Wiley Online Library Free Content; Wiley Online Library All Journals |
| subjects | Adult Aged brexucabtagene autoleucel BTK inhibitor chimeric antigen receptor therapy Disease Management Female Hematology Humans ibrutinib Immunotherapy, Adoptive - methods Lymphoma, Mantle-Cell - therapy Male Mantle cell lymphoma Mantle cell lymphoma (MCL) Middle Aged non‐Hodgkin lymphoma Receptors, Chimeric Antigen - therapeutic use Survival Analysis Treatment Outcome venetoclax |
| title | Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T18%3A02%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20and%20management%20of%20patients%20with%20mantle%20cell%20lymphoma%20after%20progression%20on%20brexucabtagene%20autoleucel%20therapy&rft.jtitle=British%20journal%20of%20haematology&rft.au=Jain,%20Preetesh&rft.date=2021-01&rft.volume=192&rft.issue=2&rft.spage=e38&rft.epage=e42&rft.pages=e38-e42&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.17197&rft_dat=%3Cproquest_cross%3E2458034789%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2478474412&rft_id=info:pmid/33152104&rfr_iscdi=true |